XORTX Therapeutics (XRTX) Capital Leases (2023 - 2026)
XORTX Therapeutics (XRTX) posted Capital Leases of $15056.0 for Q1 2026, down 59.62% on a QoQ basis from $37287.0 in Q4 2025, and down 3.87% year-over-year from $15662.0 in Q1 2025.
XORTX Therapeutics (XRTX) Capital Leases (2023 - 2026) Analysis & Trends
XORTX Therapeutics' Capital Leases history runs 4 years deep, the most recent figure standing at $15056.0 for Q1 2026.
- Quarterly Capital Leases fell 3.87% year-over-year to $15056.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $15056.0 (down 3.87% YoY) and the FY2025 annual result came in at $37287.0, down 3.86% from the prior year.
- Capital Leases was $15056.0 for Q1 2026 at XORTX Therapeutics, down from $37287.0 in the prior quarter.
- Across five years, Capital Leases topped out at $83706.0 in Q2 2024 and bottomed at $11510.0 in Q4 2023.
- A 4-year average of $44782.3 and a median of $38785.0 in 2024 frame the typical range for Capital Leases.
- Annual changes were most pronounced in 2024 — Capital Leases soared 236.97% — and 2026, when it slipped 3.87%.
- XORTX Therapeutics' Capital Leases stood at $11510.0 in 2023, then surged by 236.97% to $38785.0 in 2024, then declined by 3.86% to $37287.0 in 2025, then slumped by 59.62% to $15056.0 in 2026.
- Business Quant data shows XRTX's Capital Leases at $15056.0 in Q1 2026, $37287.0 in Q4 2025, and $59094.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | XORTX Therapeutics | 20.40 Mn | 20.40 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15,056.00 |
| Dec 31, 2025 | 37,287.00 |
| Sep 30, 2025 | 59,094.00 |
| Jun 30, 2025 | 80,473.00 |
| Mar 31, 2025 | 15,662.00 |
| Dec 31, 2024 | 38,785.00 |
| Sep 30, 2024 | 61,468.00 |
| Jun 30, 2024 | 83,706.00 |
| Dec 31, 2023 | 11,510.00 |